Breast |
Invasion and Migration |
Calcium-dependent c-Src and PKCα-ezrin pathway |
[102] |
Metastasis |
Induction of EMT and stemness |
[120] |
Doxorubicin-resistance |
AMPK/mTOR/ULK1 and JNK signaling pathways |
[137] |
Chemoresistance and stemness |
STAT 3 pathway |
[40] |
Progression |
Induction of EMT and stemness by TLR4/NF-κB/S TAT3 signaling pathway |
[19] |
Colorectal |
CRC stage progression |
Higher levels of resistin |
[138] |
G1 arrest of cells |
ERK/ SOCS3/ JAK2/STAT3 pathway |
[88] |
Inhibition to apoptosis by 5-fluorouracil |
G1 arrest of cells |
[88] |
Endothelial adhesion |
NF-κβ pathway and expression of ICAM-1A and VCAM-1 |
[104] |
Myeloma |
Multidrug resistance |
NF-κB and PI3K/Akt pathways and ABC transporter |
[97] |
Ovarian |
Angiogenesis |
PI3K/Akt-Sp1 pathway and VEGF expression |
[124] |
Invasion and Cisplatin-resistance |
Induction of EMT and stemness by tumor suppressor miRNAs, let-7a, miR-200c, and miR-186 |
[89] |
Gastric |
SDF-1 expression |
p38 MAPK and NF-κβ pathway |
[139] |
Prostate |
Cell proliferation |
PI3K/Akt signaling pathways |
[91] |
Liver |
Adhesion to human umbilical vein endothelial cells (HUVECs) |
NF-κB-regulated ICAM-1 and VCAM-1 expression |
[103] |
Pancreatic |
Proliferation, migration, invasion and gemcitabine resistance |
STAT3 signaling pathway |
[20] |
Lung |
Development and metastasis |
Expression of Wolf-Hirschhorn syndrome candidate 1 (WHSC1) histone methyltransferase and TWIST |
[53] |
Invasion and metastasis |
TLR4/Src/EGFR/PI3K/NF-κβ pathway |
[101] |